2012
DOI: 10.2337/dc11-2216
|View full text |Cite|
|
Sign up to set email alerts
|

Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
279
3
22

Year Published

2012
2012
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 320 publications
(309 citation statements)
references
References 109 publications
(289 reference statements)
5
279
3
22
Order By: Relevance
“…The levels (>65 %) would be classified as 'high carbohydrate' according to Wheeler et al (63) . Wheeler et al's (63) review indicated a non-unanimous agreement on the percentage of energy from carbohydrates shown to confer optimal glycaemic control due to conflict in results for various levels of carbohydrate in the reviewed studies. Therefore, it cannot be concluded that the high carbohydrate intake in our study contributed to the non-significant changes in glycaemic control.…”
Section: Discussionmentioning
confidence: 99%
“…The levels (>65 %) would be classified as 'high carbohydrate' according to Wheeler et al (63) . Wheeler et al's (63) review indicated a non-unanimous agreement on the percentage of energy from carbohydrates shown to confer optimal glycaemic control due to conflict in results for various levels of carbohydrate in the reviewed studies. Therefore, it cannot be concluded that the high carbohydrate intake in our study contributed to the non-significant changes in glycaemic control.…”
Section: Discussionmentioning
confidence: 99%
“…Studies in patients with varying stages of diabetic kidney disease have shown that the limitation of dietary protein to avoid excess intake slows the progression of albuminuria, GFR decline, and occurrence of ESRD (31)(32)(33)(34), although more recent studies have provided conflicting results (35). Dietary protein limitation, if protein intake is high, is a consideration particularly in patients whose diabetic kidney disease is progressing despite optimal glucose and blood pressure control and use of an ACE inhibitor or ARB (34).…”
Section: Combination Therapymentioning
confidence: 99%
“…Dicha terapia ha demostrado disminución de la Hb1AC entre 0,5%-2%, y disminución de complicaciones microvasculares (3)(4)(5).…”
Section: Introductionunclassified